Evaluation of recurrent parathyroid carcinoma: A new imaging tool in uncommon entity

Parathyroid carcinoma (PTC) is a rare endocrine tumor and uncommon cause for primary hyperparathyroidism. (18)F-fluorocholine (FCH) positron emission tomography and computed tomography (PET/CT) has shown promising results in the detection of parathyroid adenoma, though its role in PTC is undefined d...

Descripción completa

Detalles Bibliográficos
Autores principales: Thanseer, N. T. K., Parihar, Ashwin Singh, Sood, Ashwani, Bhadada, Sanjay Kumar, Dahiya, Divya, Singh, Priyanka, Mittal, Bhagwant Rai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476256/
https://www.ncbi.nlm.nih.gov/pubmed/31040757
http://dx.doi.org/10.4103/wjnm.WJNM_67_18
Descripción
Sumario:Parathyroid carcinoma (PTC) is a rare endocrine tumor and uncommon cause for primary hyperparathyroidism. (18)F-fluorocholine (FCH) positron emission tomography and computed tomography (PET/CT) has shown promising results in the detection of parathyroid adenoma, though its role in PTC is undefined due to the paucity of incidence. The authors in this case report discuss the possible complimentary role of FCH PET/CT with (18)F-fluorodeoxyglucose PET/CT in the evaluation of the management of suspected recurrence, since this rare entity has high loco-regional and distant recurrence of the disease.

Ejemplares similares